Microfluidics and Lab-on-a-chip Technology Enabling Point-of-Care Diagnostics

Microfluidics and Lab-on-a-chip Technology Enabling Point-of-Care Diagnostics

These miniaturized devices, often referred to as biochips, can perform complex laboratory analyses and medical tests using extremely small fluid volumes and portable equipment. With their small size, low cost, fast results and ease of use, biochips hold great promise to revolutionize healthcare and make powerful diagnostics widely available outside of traditional laboratory settings.

What are Lab-on-a-chip and Microarray Biochips?

Lab-on-a-chip or microfluidic biochips mimic traditional laboratory processes and fluid flow on a tiny, usually micrometer-scale integrated circuit chip. These miniaturized “labs” can analyze chemical, biochemical and biological materials on millimeter-sized chambers and fluidic channels. Depending on their application, biochips may integrate various functions like sample preparation, detection and analysis. Microarray biochips involve miniaturizing techniques such as DNA microarrays, Western blotting, and protein peptide arrays to allow analyzing thousands of biomolecular interactions simultaneously.

Applications in Point-of-Care Diagnostics

Lab-on-a-chip technology is finding a wide array of biomedical applications in areas like disease diagnostics, drug screening and toxicity testing. Perhaps one of the most promising uses is for rapid, low-cost point-of-care diagnostic testing. By consolidating sample-in to result-out processes on a single chip, biochips are ideal for applications such as bedside or home medical testing that do not require centralized laboratory facilities or highly trained personnel. Some key point-of-care applications include:

- Infectious Disease Testing - Biochips can test clinical samples for viruses, bacteria or other pathogens in a matter of minutes versus hours or days. This enables fast diagnosis and treatment decisions for diseases like HIV, flu, tuberculosis and sepsis.

- Blood Analysis - Biochips can efficiently analyze blood components like cells, proteins, enzymes and metabolites to screen for conditions like anemia, kidney disorders and metabolic diseases. Portable haematology analyzers using biochip technology are now available.

- Cardiac Marker Testing - Biochips can rapidly detect markers for heart attack like troponin levels from a finger-prick worth of blood, helping paramedics triage patients in the field.

- Cancer Screening - Microarray biochips can examine tumor marker levels, genetic mutations and protein expression patterns to aid cancer diagnosis and monitoring.

Advantages Over Traditional Methods

Biochips offer several advantages over standard laboratory diagnostic methods:

Miniaturization - Lab-On-A-Chip And Microarrays  benchtop laboratory equipment, reagents and processes onto a single, handheld microchip that requires very small sample volumes in the range of microliters or less.

Low Cost - Integrating several diagnostic steps on a single chip reduces costs by minimizing expensive equipment, reagents and technician time required. Mass production further cuts unit costs to just a few dollars per test.

Rapidity - Automated biochip processes can return results in minutes instead of hours or days. Sample-to-result times are faster due to short diffusion lengths, rapid mixing at the microscale and high surface area-to-volume ratios.

Simple Operation - Biochips are designed for ease-of-use with basic skills. Lay users can perform point-of-care tests via integrated fluid handling, incubation, detection and readout without special training.

Portability - Small, lightweight, self-contained biochip devices can perform complex assays outside central labs, at the bedside, in clinics, remote areas and even homes. This improves accessibility.

Standardization - Integrated fluidics and mechanics standardize each biochip assay and produce consistent, reproducible results eliminating technician-to-technician variability.

Commercialization and Future Outlook

With the above advantages, microfluidic and biochip technology is gaining commercial acceptance. Major diagnostic firms are marketing biochip-based platforms and tests for detection of diseases like influenza, HIV and cancer. Portable and handheld biochip devices for telemedicine and home healthcare are in development stages. Future advancements like 3D printing and flexible, paper-based biochips promise even more widespread application beyond medical settings. Overall, as the technology matures, lab-on-a-chip is set to revolutionize diagnostics and bring sophisticated medical testing to the point-of-care. This will significantly benefit global healthcare by enabling faster, cheaper and more accessible diagnostic services where they are needed most.
 
For More details on the topic:
https://www.newswirestats.com/lab-on-a-chip-and-microarrays-size-and-share-analysis/